|
"Teen
deaths from Ecstasy rise along with popularity"
(...headline of article in
The Orange County Register, Saturday April 28, 2001)
"ECSTASY"- MDMA
MDMA, called "Adam," "ecstasy," or "XTC"
on the street, is a synthetic, psychoactive (mind-altering) drug with
amphetamine-like and hallucinogenic properties. Its chemical structure
(3-4 methylenedioxymethamphetamine) is similar to two other synthetic
drugs, MDA and methamphetamine, which are known to cause brain damage.
Health Hazards
Beliefs about MDMA are reminiscent of the
claims made about LSD in the 1950s and 1960s, which proved to be untrue.
According to its proponents, MDMA can make people trust each other and
can break down barriers between therapists and patients, lovers, and
family members.
Many of the risks users face with MDMA
use are similar to those found with the use of amphetamines and cocaine.
They are:
- Psychological difficulties, including
confusion, depression, sleep problems, drug craving, severe anxiety,
and paranoia - during and sometimes weeks after taking MDMA (even
psychotic episodes have been reported).
- Physical symptoms such as muscle
tension, involuntary teeth clenching, nausea, blurred vision, rapid
eye movement, faintness, and chills or sweating.
- Increases in heart rate and blood
pressure, a special risk for people with circulatory or heart
disease.
Recent research findings also link MDMA
use to long-term damage to those parts of the brain critical to thought
and memory. It is thought that the drug causes damage to the neurons
that use the chemical serotonin to communicate with other neurons. In
monkeys, exposure to MDMA for 4 days caused brain damage that was
evident 6 to 7 years later. This study provides further evidence that
people who take MDMA may be risking permanent brain damage.
Also, there is evidence that people who
develop a rash that looks like acne after using MDMA may be risking
severe side effects, including liver damage, if they continue to use the
drug.
MDA, the parent drug of MDMA, is an
amphetamine-like drug that has also been abused and is similar in
chemical structure to MDMA. Research shows that MDA destroys serotonin-producing
neurons in the brain, which play a direct role in regulating aggression,
mood, sexual activity, sleep, and sensitivity to pain. It is probably
this action on the serotonin system that gives MDA its purported
properties of height-ened sexual experience, tranquillity, and
conviviality.
MDMA also is related in its structure and
effects to methamphetamine, which has been shown to cause degeneration
of neurons containing the neurotransmitter dopamine. Damage to these
neurons is the underlying cause of the motor disturbances seen in
Parkinson's disease. Symptoms of this disease begin with lack of
coordination and tremors and can eventually result in a form of
paralysis.
Extent of Use
Community Epidemiology Work Group (CEWG)*
MDMA is used most often by young adults
and adolescents at clubs, raves (large, all-night dance parties), and
rock concerts.
Its abuse is increasingly reported in the
20 metropolitan areas included in the CEWG.
In Kings County, Washington, a recently
completed survey of young men who have sex with men showed that MDMA was
among the frequently used drugs (20 percent of the sample).
In Boston, a 1996-97 survey of public
schools in Boston found that about 14 percent of male and 7 percent of
female 12th graders had used MDMA during their lifetime. Increased use
of MDMA among youth was also reported in Seattle.
Information about MDMA from other CEWG
areas include the following:
- In Atlanta, MDMA is reported as a
popular stimulant.
- In Chicago, it's use is common in the
rave and club scenes, especially in the North Side.
- In Miami, large-scale sales of drugs
such as MDMA are occurring at raves.
- In New Jersey, it is available across
the state, particularly in college towns.
National Household Survey on Drug
Abuse (NHSDA)**
Each year, NHSDA reports on the nature
and extent of drug use among the American household population aged 12
and older. The 1998 survey found that an estimated 1.5 percent (3.4
million) of Americans at least 12 years old had used MDMA at least once
during their lifetime. By age group, the heaviest use (5 percent or 1.4
million people) was reported for those between 18 and 25 years old.
Monitoring the Future Study (MTF)***
In 1996, MTF began to collect data on
MDMA use among students. Rates of use remained relatively stable from
1996 to 1999 for students in the 8th grade, while usage among 10th- and
12th-graders has increased.
The number of 12th-graders that had used
MDMA in their lifetime increased from 5.8 percent in 1998 to 8.0 percent
in 1999. Use in the past year also increased from 3.6 percent in 1998 to
5.6 percent in 1999. In addition, 12th-graders use of MDMA in the past
month also increased from 1.5 percent in 1998 to 2.5 percent in 1999.
On the other hand, the largest change for
10th-graders occurred in past year use, which increased from 3.3 percent
in 1998 to 4.4 percent in 1999.
Ecstasy Use by
Students, 1999:
Monitoring the Future Study
| |
8th-Graders
| 10th-Graders
| 12th-Graders
|
| Ever Used
| 2.7% |
6.0% |
8.0% |
| Used in Past
Year
| 1.7 |
4.4 |
5.6 |
| Used in Past
Month
| 0.8 |
1.8 |
2.5 |
"Ever used" refers to use at
least once during a respondent's lifetime. "Past year" refers
to an individual's drug use at least once during the year preceding
their response to the survey. "Past month" refers to an
individual's drug use at least once during the month preceding their
response to the survey.
* CEWG
is a NIDA-sponsored network of researchers from 21 major U.S.
metropolitan areas and selected foreign countries who meet semiannually
to discuss the current epidemiology of drug abuse. CEWG's most recent
reports are available on the CEWG web site.
** NHSDA is an annual survey conducted by
the Substance Abuse and Mental Health Services administration. Copies of
the latest survey are available from the National Clearinghouse for
Alcohol and Drug Information at 1-800-729-6686.
*** MTF is an annual survey on drug use
and related attitudes of America's adolescents that began in 1975. In
1996, MTF began to collect data on MDMA use among students. The survey
is conducted by the University of Michigan's Institute for Social
Research and is funded by NIDA. Copies of the latest survey are
available from the National Clearinghouse for Alcohol and Drug
Information at 1-800-729-6686.
|